sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has publicly disclosed its position in Mural Oncology plc through a regulatory filing. According to the disclosure, The Vanguard Group holds 727,309 ordinary shares of Mural Oncology plc, which represents 4.21% of the relevant securities. This is in adherence to the Irish Takeover Panel Act, 1997 and Takeover Rules, 2022. The detailed document indicates there have been sales of 43,686 ordinary shares at a price of 2.08 USD per unit.
Furthermore, the filing specifies that there are no cash-settled or stock-settled derivatives, nor are there any agreements to buy or sell securities. Additionally, no indemnities, agreements, or arrangements concerning these securities are in place. This filing provides transparency on Vanguard's stake and trading activities in Mural Oncology.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.